These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 23405077)
1. Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis. Liu Y; Li L; Qi H; Gao Y; Liu S; Xu C PLoS One; 2013; 8(2):e54081. PubMed ID: 23405077 [TBL] [Abstract][Full Text] [Related]
2. Association between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studies. Qin Q; Zhang C; Zhu H; Yang X; Xu L; Liu J; Lu J; Zhan L; Cheng H; Sun X J Cancer Res Clin Oncol; 2014 Feb; 140(2):179-88. PubMed ID: 24077840 [TBL] [Abstract][Full Text] [Related]
3. Survivin promoter -31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis. Srivastava K; Srivastava A; Mittal B Mol Biol Rep; 2012 Feb; 39(2):1509-16. PubMed ID: 21611748 [TBL] [Abstract][Full Text] [Related]
4. Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis. Wang X; Huang L; Xu Y; Shi Z; Wang Y; Zhang J; Wang X; Cao L; Luo H; Chen J; Liu N; Yin Y; You Y Eur J Hum Genet; 2012 Jul; 20(7):790-5. PubMed ID: 22274581 [TBL] [Abstract][Full Text] [Related]
5. Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies. Xu L; Zhou X; Xu L; Yin R Tumour Biol; 2014 Feb; 35(2):1661-9. PubMed ID: 24096544 [TBL] [Abstract][Full Text] [Related]
6. Survivin c.-31G>C (rs9904341) gene transversion and urinary system cancers risk: a systematic review and a meta-analysis. Mazoochi T; Karimian M; Ehteram H; Karimian A Per Med; 2019 Jan; 16(1):67-78. PubMed ID: 30465472 [TBL] [Abstract][Full Text] [Related]
7. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population. Rasool I; Afroze D; Wani KA; Yousuf A; Bhat IA; Rah B; Nazir SU; Hussain S; Dubey S Clin Breast Cancer; 2018 Aug; 18(4):e671-e676. PubMed ID: 29233639 [TBL] [Abstract][Full Text] [Related]
8. Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study. Chen J; Cui X; Zhou H; Qin C; Cao Q; Ju X; Li P; Cai H; Zhu J; Meng X; Wang M; Zhang Z; Shao P; Li J; Yin C BMC Cancer; 2013 Jul; 13():356. PubMed ID: 23883402 [TBL] [Abstract][Full Text] [Related]
9. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population. Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057 [TBL] [Abstract][Full Text] [Related]
10. The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population. Yang L; Zhu H; Zhou B; Gu H; Yan H; Tang N; Dong H; Sun Q; Cong R; Chen G; Wang B Dig Dis Sci; 2009 May; 54(5):1021-8. PubMed ID: 18716870 [TBL] [Abstract][Full Text] [Related]
11. HIF-1α C1772T polymorphism and gastrointestinal tract cancer risk: a meta-analysis and meta-regression analysis. Xu J; Xu L; Li L; You Q; Cha L Genet Test Mol Biomarkers; 2013 Dec; 17(12):918-25. PubMed ID: 24063654 [TBL] [Abstract][Full Text] [Related]
12. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis. Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233 [TBL] [Abstract][Full Text] [Related]
13. Survivin and angiotensin-converting enzyme polymorphisms with risk of colorectal cancer: a systematic review and meta-analysis. Zhou X; Lin C World J Surg Oncol; 2015 Feb; 13():27. PubMed ID: 25889770 [TBL] [Abstract][Full Text] [Related]
14. Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development. Kostić M; Nikolić N; Ilić B; Carkić J; Milenković S; Vukadinović M Srp Arh Celok Lek; 2013; 141(5-6):304-7. PubMed ID: 23858797 [TBL] [Abstract][Full Text] [Related]
15. Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort. Jaiswal PK; Goel A; Mandhani A; Mittal RD Mol Biol Rep; 2012 May; 39(5):5615-21. PubMed ID: 22193624 [TBL] [Abstract][Full Text] [Related]
16. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population. Bayram S; Akkız H; Bekar A; Akgöllü E Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634 [TBL] [Abstract][Full Text] [Related]
17. Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India. Upadhyay R; Khurana R; Kumar S; Ghoshal UC; Mittal B Ann Surg Oncol; 2011 Mar; 18(3):880-7. PubMed ID: 20957442 [TBL] [Abstract][Full Text] [Related]
18. The association between survivin -31G>C polymorphism and susceptibility to sporadic colorectal cancer in a Southern Chinese population. Huang J; Wei Y; Zhou X; Wang L; Huang M; Wang J J Cancer Res Ther; 2019; 15(1):82-86. PubMed ID: 30880759 [TBL] [Abstract][Full Text] [Related]
19. Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case-control studies. Moazeni-Roodi A; Ghavami S; Hashemi M Int J Clin Oncol; 2019 Apr; 24(4):335-349. PubMed ID: 30747314 [TBL] [Abstract][Full Text] [Related]
20. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression. Li YL; Tian Z; Zhao L; Zhang CL Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]